Navigation Links
QIAGEN Unveils Initiative to Create Next-Generation Sequencing Portfolio for use in Clinical Research and Molecular Diagnostics
Date:6/25/2012

HILDEN, Germany and GERMANTOWN, Maryland, June 25, 2012 /PRNewswire/ --

  • Aim to expand next-generation sequencing beyond current focus on life sciences research
  • QIAGEN plans to offer sample-to-result workflows that integrate its sample preparation and assay products with a next-generation benchtop sequencer and new bioinformatics
  • Initiative combines broad range of QIAGEN products with acquisition of sequencing specialist Intelligent Bio-Systems, Inc. and a new strategic collaboration with SAP AG

QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today unveiled an advanced initiative to enter the field of next-generation sequencing (NGS) that aims to establish these technologies as routine processes used in new areas such as clinical research and molecular diagnostics.

QIAGEN is in the advanced stages of creating sample-to-result, efficient and cost-effective NGS workflow solutions. These will combine a broad range of QIAGEN products - including automated sample preparation solutions (nucleic acid extraction, DNA enrichment, library preparation and targeted gene analysis panels) - with a previously undisclosed next-generation benchtop sequencer in development with Intelligent Bio-Systems, Inc., a privately held company that QIAGEN has acquired. New bioinformatics, including solutions emerging from a new collaboration with SAP AG, will be incorporated into the workflows. A first sample-to-result NGS solution is expected to be launched next year, while details on specifications and launch plans are set to be released in early 2013.

"The rapid advances in next-generation sequencing have enabled life science researchers to unlock many secrets about the molecular building blocks of life. Our ambition is to create a new dimension of benefits for these technologies by offering workflow solut
'/>"/>

SOURCE QIAGEN N.V.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. QIAGEN and Cardinal Health Collaborate to Offer Molecular Diagnostic Products to Smaller and Mid-sized U.S. Hospitals
2. BioDrain Medical, Inc. Implements Initiatives to Position Itself for Sustained Growth
3. Kansas City Region Launches Contract Research Initiative To Speed The Development Of Health Care Innovation Worldwide
4. Uroplasty Announces Product Development and New Clinical Trial Initiatives
5. Herborium Announces Continuing Progress In Key Strategic Initiatives
6. Warning: Not All Cold Sore Medicines Are Created Equal
7. Chinese Compulsory Immunization Program for Livestock Creates Massive Opportunity for Animal Vaccines and Biologics Developers
8. Kill the Germs, Spare the Ears: Study Shows How to Create Effective Antibiotics That Dont Damage Hearing
9. Quest Diagnostics Establishes Unique Healthcare Identifier to Improve Access to Vital Patient Health Information; 80 Million Patient IDs Created to Date
10. MicuRx Pharmaceuticals Announces Issuance Of U.S. Patent For Its Next-Generation Antibacterial Agent
11. Remedy Informatics to Debut SpecimenTrack, Next-Generation Biorepository Software at ISBER 2012 Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/6/2015)... , July 6, 2015  Array BioPharma Inc. ... Chief Executive Officer, Ron Squarer , will ... in New York City.  The public is welcome ... on the Array BioPharma website. Event: Cantor Fitzgerald 2015 ... 2015Time:1:00 p.m. Eastern Time Webcast: www.arraybiopharma.com About Array ...
(Date:7/6/2015)... 2015  OrthoSpace Ltd. ("OrthoSpace" or "Company") announced ... in its US Investigational Device Exemption (IDE) pivotal ... single blinded control study that compares the Company,s ... partial repair for the treatment of full thickness ... commercially available outside of the United ...
(Date:7/6/2015)... 2015 Mauna Kea Technologies ... confocal laser endomicroscopy platform, announced today it has ... Ministry of Health, Labor and Welfare (MHLW) for ... AQ-Flex 19 miniprobe.   Used during ... is comprised of a fiber-optic microscope that is ...
Breaking Medicine Technology:OrthoSpace Enrolls First Patients in US IDE Study 2Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 2Mauna Kea Technologies Receives Regulatory Approval for the AQ-Flex 19 Miniprobe in Japan 3
... WIRE)--Jun 21, 2007 - BioSante,Pharmaceuticals, Inc. (AMEX:BPA) ... (WHI) Coronary Artery Calcium Study,published yesterday in ... study found that younger menopausal women (aged ... therapy had significantly less,coronary artery calcification at ...
... announced clinical,results from the first of five phase ... analogue. The 26-week study is part of,the LEAD(TM) ... 581 patients with type 2 diabetes inadequately,controlled by ... drugs:,metformin and a sulfonylurea (glimepiride). All patients in ...
Cached Medicine Technology:New Analysis of WHI Data Shows Reduced Levels of Coronary Artery,Calcification, a Predictor of Cardiovascular Events, in Women aged,50-59 taking Estrogen Therapy 2New Analysis of WHI Data Shows Reduced Levels of Coronary Artery,Calcification, a Predictor of Cardiovascular Events, in Women aged,50-59 taking Estrogen Therapy 3New Analysis of WHI Data Shows Reduced Levels of Coronary Artery,Calcification, a Predictor of Cardiovascular Events, in Women aged,50-59 taking Estrogen Therapy 4Liraglutide provides significantly better glucose control than,insulin glargine in phase 3 study 2Liraglutide provides significantly better glucose control than,insulin glargine in phase 3 study 3Liraglutide provides significantly better glucose control than,insulin glargine in phase 3 study 4
(Date:7/7/2015)... ... 07, 2015 , ... CSG Government Solutions, a ... the Department of Vermont Health Access to provide Quality Assurance (QA) and Independent ... Integrated Contact Center System project. , Vermont is implementing a strategic approach to ...
(Date:7/6/2015)... ... July 07, 2015 , ... Currently, mobile testing ... of AIDS, advances in the molecular diagnostic technologies, wide availability of immunosuppressive drugs ... detection technologies and genetic engineering also open lucrative opportunities for the market players. ...
(Date:7/6/2015)... Laguna Woods, CA (PRWEB) , ... July 06, ... ... first Water Revival System that eliminates 100% of all acids, chemicals and impurities; ... not suggested for drinking water because it contains harmful contaminants.  These harmful contaminants ...
(Date:7/6/2015)... , ... July 06, 2015 , ... ... of orthopaedic sports medicine, the American Orthopaedic Society for Sports Medicine ( AOSSM ... July 9-12 in Orlando, FL. As a leader in orthopaedic sports medicine, ...
(Date:7/6/2015)... ... July 06, 2015 , ... Acara Partners, a leading business ... of its complimentary educational webinar series for the summer of 2015. ... for their clients through targeted marketing, sales, digital communications, branding and business development ...
Breaking Medicine News(10 mins):Health News:CSG Government Solutions Selected by the Department of Vermont Health Access to Provide Quality Assurance and Independent Verification and Validation Services 2Health News:World Infectious Disease Testing Market Examined by VPGMarketResearch.com in In-Demand Report Available at MarketPublishers.com 2Health News:World Infectious Disease Testing Market Examined by VPGMarketResearch.com in In-Demand Report Available at MarketPublishers.com 3Health News:Pristine Water Filters.com Offers The 1st Water Revival System That Re-Mineralizes Drinking Water and Eliminates All Impurities and Chemicals 2Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 2Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 3Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 4Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 5Health News:American Orthopaedic Society for Sports Medicine (AOSSM) Presents Prestigious Research Awards at Annual Meeting 6Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 2Health News:Acara Partners Announces Complimentary Educational Webinar Series for Cosmetic Medical Practices and MedSpas 3
... , , , , ... pleased to announce its recent Angel Grant recipients, which include: ... Blatt of the University of North Carolina - Chapel Hill, Dr. Jeffrey ... the University of Chicago. , , Steven S. ...
... , , , ... today announced financial results for its fiscal 2010 first quarter ended June ... with $311.6 million in the first quarter of fiscal 2009, a decline ... Operating profit increased 22% to $42.9 million, or 15.1% of revenues, compared ...
... , BIRMINGHAM, Ala., July 30 BioCryst ... results for the quarter and six months ended June 30, ... potential emergency use of intravenous (i.v.) peramivir in the U.S. ... focused on moving our leading peramivir and forodesine clinical development ...
... PARK CITY, Utah, July 30 Nutraceutical International Corporation (Nasdaq: ... third quarter ended June 30, 2009. Net sales for the fiscal ... same quarter of fiscal 2008. For the third quarter of fiscal ... compared to net income of $2.9 million, or $0.26 diluted earnings per ...
... , , , ... a leading provider of information and business intelligence for students, ... the pharmaceutical industry, today launched an enhanced version of AdisOnline ... ), providing a host of user-customizable features and purchasing options ...
... ... low noise plastic and steel gearing options. , ... Chatsworth, CA (PRWEB) -- NMB Technologies Corporation, a Minebea Company, introduced today ... medical industry, as well as for pumps, valves and material handling equipment., , , , ...
Cached Medicine News:Health News:National Cancer Coalition Announces Angel Grant Recipients 2Health News:STERIS Corporation Announces Fiscal 2010 First Quarter Results 2Health News:STERIS Corporation Announces Fiscal 2010 First Quarter Results 3Health News:STERIS Corporation Announces Fiscal 2010 First Quarter Results 4Health News:STERIS Corporation Announces Fiscal 2010 First Quarter Results 5Health News:STERIS Corporation Announces Fiscal 2010 First Quarter Results 6Health News:STERIS Corporation Announces Fiscal 2010 First Quarter Results 7Health News:STERIS Corporation Announces Fiscal 2010 First Quarter Results 8Health News:STERIS Corporation Announces Fiscal 2010 First Quarter Results 9Health News:STERIS Corporation Announces Fiscal 2010 First Quarter Results 10Health News:STERIS Corporation Announces Fiscal 2010 First Quarter Results 11Health News:BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update 2Health News:BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update 3Health News:BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update 4Health News:BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update 5Health News:BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update 6Health News:BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update 7Health News:BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update 8Health News:BioCryst Reports Second Quarter 2009 Financial Results And Provides Corporate Update 9Health News:Nutraceutical Reports Fiscal 2009 Q3 Results and Expands Share Repurchase Program 2Health News:Nutraceutical Reports Fiscal 2009 Q3 Results and Expands Share Repurchase Program 3Health News:Nutraceutical Reports Fiscal 2009 Q3 Results and Expands Share Repurchase Program 4Health News:Nutraceutical Reports Fiscal 2009 Q3 Results and Expands Share Repurchase Program 5Health News:Nutraceutical Reports Fiscal 2009 Q3 Results and Expands Share Repurchase Program 6Health News:Nutraceutical Reports Fiscal 2009 Q3 Results and Expands Share Repurchase Program 7Health News:Nutraceutical Reports Fiscal 2009 Q3 Results and Expands Share Repurchase Program 8Health News:Wolters Kluwer Health Launches Interactive Platform for Pharmacology Journal Content 2Health News:Wolters Kluwer Health Launches Interactive Platform for Pharmacology Journal Content 3Health News:Wolters Kluwer Health Launches Interactive Platform for Pharmacology Journal Content 4Health News:New Custom Hybrid Planetary Gearbox Series from NMB 2
... cleanser will not leave your hands dry, ... With persistent Antimicrobial action, CHG Skin Cleanser ... gram-negative and gram-positive bacteria, fungi, and yeasts. ... second hand wash. The solution does not ...
IV Prep Antiseptic Wipes are effective and easy to apply. They are ideal for preparation of the skin prior to a ventipuncture or injection....
Aplicare's Prep Pads offer convenience, low cost, ease of use. The medium size is appropriate for most applications. Each package is terminally sterilized, ensuring the safest possible product for th...
... Triad Plus Skin Protectant Swabsticks prepare ... dressing or bandage. When dry, they leave ... This provides a clean surface and a ... affect the adhesion of a dressing or ...
Medicine Products: